Gill F M, Schwartz E
J Clin Invest. 1973 Mar;52(3):709-14. doi: 10.1172/JCI107232.
In five patients with sickle beta-thalassemia there was balanced alpha- and beta-globin synthesis in the bone marrow and decreased total beta-chain synthesis relative to that of alpha-chain in the peripheral blood. These findings are similar to those in patients with simple beta-thalassemia trait. Despite a range of hemoglobin concentrations from 6.8 to 12.5 g/100 ml in the patients with sickle thalassemia, there was no evidence of a significant excess of alpha-chains in the red cells of the bone marrow which could contribute to the hemolysis and anemia. In patients heterozygous for beta-thalassemia the capacity to synthesize beta-chain decreases more rapidly than that for alpha-chain. In nonthalassemic subjects the rates of beta- and alpha-chain synthesis decrease equally as the red cell matures. The beta(S)- and beta(A)-chains serve as convenient markers for globin synthesis due to the nonthalassemic and thalassemic alleles in patients with sickle beta-thalassemia. The unbalanced globin synthesis in the peripheral blood of these patients is explained by the decrease in relative synthesis of beta(S)-chain, in comparison with that of alpha-chain. This instability is not present in sickle cell trait. The beta(A)-chain synthesis was only unstable in the two patients who had the most marked anemia. The major mechanism for achieving balanced globin production in the bone marrow in the presence of one thalassemic gene appears to be increased synthesis of beta-chain due to the nonthalassemic allele. In addition, there may be a decrease of total alpha-chain synthesis in some patients.
在5例镰状β地中海贫血患者中,骨髓内α和β珠蛋白合成平衡,而外周血中β链总合成量相对于α链减少。这些发现与单纯β地中海贫血特征患者的情况相似。尽管镰状地中海贫血患者的血红蛋白浓度范围为6.8至12.5g/100ml,但骨髓红细胞中没有证据表明存在显著过量的α链,而α链过量可能导致溶血和贫血。在β地中海贫血杂合子患者中,β链合成能力的下降比α链更快。在非地中海贫血受试者中,随着红细胞成熟,β链和α链的合成速率同等下降。由于镰状β地中海贫血患者存在非地中海贫血和地中海贫血等位基因,β(S)链和β(A)链可作为珠蛋白合成的便捷标记。与α链相比,这些患者外周血中β(S)链相对合成量减少,解释了珠蛋白合成失衡的现象。镰状细胞特征患者不存在这种不稳定性。仅在两名贫血最为明显的患者中,β(A)链合成不稳定。在存在一个地中海贫血基因的情况下,骨髓中实现珠蛋白平衡产生的主要机制似乎是由于非地中海贫血等位基因导致β链合成增加。此外,部分患者的α链总合成量可能会减少。